ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM (NCT05283109)
ETAPA I: Evaluation of Tumor Associated P30-Peptide Antigen I; A Pilot Trial of Peptide-based Tumor Associated Antigen Vaccines in Newly Diagnosed, Unmethylated, and Untreated Glioblastoma (GBM)
🩺 Plain-English Summary (8th-Grade Level)
This is a phase 1b study of P30-linked EphA2, CMV pp65, and survivin vaccination (collectively called the P30-EPS vaccine) in HLA-A\*0201 positive patients with a newly diagnosed, unmethylated, and untreated World Health Organization (WHO) grade IV malignant glioma.
Who can join: Review the eligibility criteria below.
Location: The Preston Robert Tisch Brain Tumor Center at Duke University — Durham, North Carolina
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- The Preston Robert Tisch Brain Tumor Center at Duke University — Durham, North Carolina
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Glioma, Malignant
- Safety and Tolerability of Fb-PMT in Recurrent Glioblastoma — New Haven, Connecticut
- Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma — New York, New York
- Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma — Durham, North Carolina
- Window of Opportunity Study of DSP-0390 in Gliomas — St Louis, Missouri
Explore by condition: All Glioma, Malignant clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.